You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Epithelioid Hemangioendothelioma

Showing 1 - 25 of 50
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Angiosarcoma, Epithelioid Hemangioendothelioma Trial in Boston (Eribulin)

Recruiting
  • Angiosarcoma
  • Epithelioid Hemangioendothelioma
  • Boston, Massachusetts
  • +1 more
Feb 14, 2022

Solid Tumors, Adult, Solid Tumor, Mesothelioma (MPM) Trial in United States (IK-930)

Recruiting
  • Solid Tumors, Adult
  • +7 more
  • Boston, Massachusetts
  • +6 more
Jan 24, 2023

Soft Tissue Sarcoma, Clear Cell Sarcoma, Epithelioid Sarcoma Trial in France (Patient with Soft Tissue Sarcoma)

Recruiting
  • Soft Tissue Sarcoma
  • +9 more
  • Patient with Soft Tissue Sarcoma
  • Besancon, France
  • +13 more
Oct 11, 2022

Adult Alveolar Soft Part Sarcoma, Adult Angiosarcoma, Adult Desmoplastic Small Round Cell Tumor Trial in Portland, Seattle

Completed
Has Results
  • Adult Alveolar Soft Part Sarcoma
  • +18 more
  • Portland, Oregon
  • +1 more
Sep 23, 2021

Soft Tissue Sarcoma Adult, Undifferentiated Pleomorphic Sarcoma, Epithelioid Sarcoma Trial in Bordeaux (Trabectedin)

Recruiting
  • Soft Tissue Sarcoma Adult
  • +6 more
  • Bordeaux, France
    Institut Bergonie
Feb 1, 2022

Soft Tissue Sarcoma Trial in Shanghai (Fruquintinib)

Recruiting
  • Soft Tissue Sarcoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 1, 2022

Advanced Sarcoma Trial in United States (Lenvatinib, Pembrolizumab)

Recruiting
  • Advanced Sarcoma
  • Basking Ridge, New Jersey
  • +6 more
Jul 8, 2022

Advanced and/or Metastatic Sarcoma Trial in Houston (Durvalumab, Tremelimumab)

Active, not recruiting
  • Advanced and/or Metastatic Sarcoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 7, 2022

Hemangioendothelioma of Liver Trial in Shanghai (Sirolimus Oral Product, propranolol)

Not yet recruiting
  • Hemangioendothelioma of Liver
  • Shanghai, Shanghai, China
    Shanghai Children's Medical Center Shanghai Jiaotong University
May 23, 2020

Hemangioma, Kaposiform Hemangioendothelioma Trial in Shanghai (Sirolimus(0.8mg/m2), Sirolimus(0.7mg/m2))

Completed
  • Hemangioma
  • Kaposiform Hemangioendothelioma
  • Shanghai, China
    Children's Hospital of Fudan University
Jan 27, 2023

Tacrolimus, Kaposiform Hemangioendothelioma, Tufted Angioma Trial in Chengdu (Tacrolimus ointment)

Recruiting
  • Tacrolimus, Kaposiform Hemangioendothelioma, Tufted Angioma
  • Tacrolimus ointment
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Jan 15, 2023

Objective Response, Overall Survival Trial in Beijing (VIA combination treatment)

Completed
  • Objective Response
  • Overall Survival
  • VIA combination treatment
  • Beijing, China
    Peking University People's Hospital
Dec 9, 2022

Pleural Mesothelioma Trial in Italy (Carboplatin/Cisplatin - Pemetrexed - Pembrolizumab)

Not yet recruiting
  • Pleural Mesothelioma
  • Carboplatin/Cisplatin - Pemetrexed - Pembrolizumab
  • Rozzano, MI, Italy
  • +5 more
Nov 30, 2023

Advanced Malignant Perivascular Epithelioid Cell Tumor (PEComa) Trial in Beijing (Sirolimus for Injection (Albumin Bound))

Recruiting
  • Advanced Malignant Perivascular Epithelioid Cell Tumor (PEComa)
  • Sirolimus for Injection (Albumin Bound)
  • Beijing, China
    Beijing Jishuitan Hospital
Nov 23, 2022

Hemangioendothelioma Trial in Chengdu (Sirolimus)

Recruiting
  • Hemangioendothelioma
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
May 1, 2022

Kaposiform Hemangioendothelioma Trial in Chengdu (Sirolimus)

Recruiting
  • Kaposiform Hemangioendothelioma
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Apr 6, 2022

Atypical Teratoid Rhabdoid Tumor, INI1 (SMARCB1)-Deficient Primary CNS Malignant Tumors, SMARCA4-deficient Primary CNS Malignant

Recruiting
  • Atypical Teratoid Rhabdoid Tumor
  • +6 more
  • Boston, Massachusetts
  • +1 more
Jan 23, 2023

PEComa Trial in United States (ABI-009)

Completed
  • PEComa
  • Palo Alto, California
  • +8 more
Apr 29, 2022

Histologic Prognostic Factors in Peritoneal Malignant

Recruiting
  • Peritoneal Malignant Mesothelioma
  • No intervention
  • Gent, Belgium
  • +5 more
Dec 31, 2021

Perivascular Epithelioid Cell Tumors

Recruiting
  • Perivascular Epithelioid Cell Tumor, Malignant
    • Strasbourg, France
      Service d'Oncologie - CHU de Strasbourg - France
    Nov 7, 2022

    Solid Tumor, ARID1A Gene Mutation Trial in Greenville (Tazemetostat)

    Suspended
    • Solid Tumor
    • ARID1A Gene Mutation
    • Greenville, South Carolina
      Prisma Health Cancer Institute
    Jan 10, 2023

    Malignant Rhabdoid Tumors (MRT), Rhabdoid Tumors of the Kidney (RTK), Atypical Teratoid Rhabdoid Tumors (ATRT) Trial in

    Active, not recruiting
    • Malignant Rhabdoid Tumors (MRT)
    • +10 more
    • San Francisco, California
    • +31 more
    Jan 17, 2023

    An Observational Study on Epithelioid Sarcoma

    Recruiting
    • Epithelioid Sarcoma
    • Treatment for Epitheloid Sarcoma
    • Bari, BA, Italy
    • +12 more
    Oct 29, 2021

    PEComa, Malignant, TSC1, TSC2 Trial (ABI-009)

    Approved for marketing
    • PEComa, Malignant
    • +3 more
    • (no location specified)
    Mar 2, 2022

    Kaposiform Hemangioendothelioma, Kasabach-Merritt Syndrome Trial in Shanghai (Sirolimus)

    Recruiting
    • Kaposiform Hemangioendothelioma
    • Kasabach-Merritt Syndrome
    • Shanghai, Shanghai, China
      Children's Hospital of Fudan University
    Oct 21, 2022